Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |